title: Leukaemia risk in Crohn's disease.
authors.forename: K
authors.initials: K
authors.lastname: Hatake
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Muroi
authors.forename: Y
authors.initials: Y
authors.lastname: Miura
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D003082:Colectomy; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000209:etiology*; D012306:Risk; D012460:Sulfasalazine / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D012460:Sulfasalazine